Nikki Lim

Datature simplifies the way people build deep-learning capabilities. Using Nexus, our end-to-end #nocode mlops platform, we enable everyone to create AI breakthroughs of their own.

Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA. The Company has assembled a toolkit of disruptive platform technologies – including a high payload capacity HSV platform, a hypoimmunogenic platform, and a genome writing platform – to address the scientific challenges currently limiting clinical progress and preventing genomic medicine from realising its full potential. The Company’s hub-and-spoke business model separates technology development within Replay from therapeutic development in product companies, which leverage the technology platforms. For example, Replay’s synHSV™ technology, a high payload capacity HSV vector capable of delivering up to 30 times the payload of AAV, is utilized by Replay’s four gene therapy product companies, bringing big DNA treatments to diseases affecting the skin, eye, brain, and muscle. The Company has, additionally, established an enzyme writing product company engaging its evolutionary inference machine learning and genome writing technology to optimize functionality. Replay is led by a world-class team of academics, entrepreneurs and industry experts.

Lithium battery recycling is costly, inflexible and inefficient. NEUs mission is to change that. NEU Battery Materials has developed the world’s first electrochemical lithium-ion battery recycling technology, providing a greener, scalable, and commercially viable alternative to conventional processes today. Our patented LFP-first technology enables a near-zero waste recycling process of lithium batteries. We empower automotive OEMs, cell manufacturers, and battery recyclers to lean into LFP batteries knowing there is a circular solution to recover the critical metals. Our modular recycling units only consume water and electricity to extract lithium from end-of-life lithium batteries, removing the need for costly, wasteful acid leaching or smelting processes to extract lithium. Contact us at hello@neumaterials.com Learn more and click the URL below!

Nalagenetics was built with the passion to make preventive, DNA-based precision healthcare accessible to as many people as possible. Specifically, catalyzed by the founders’ personal experiences of problematic medication side effects and knowledge of what genetic testing can offer, Nalagenetics aims to help people achieve better nutrition and prescription medication outcomes by analyzing their unique DNA. Today, Nalagenetics’ solutions are trusted by a growing number of healthcare providers, laboratories, insurers and corporates in Asia and Europe. We have also won government grants and mandates to carry out genomic research projects from the Government of Singapore and others. These achievements reflect the company’s exceptional standards and depth of research as a scientist-led company, along with a commitment to delivering best-in-class genomic solutions. Find out more about us at www.nalagenetics.com

Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.

Decoding Secreted Proteins for Chronic and Age-Related Diseases

Unlocking the potential of macrocycle drug discovery through machine learning and massively parallel synthesis

WhiteCoat is a leading telehealth provider that allows you to video consult with a trusted doctor on your smartphone. From treating common ailments to managing chronic illnesses, WhiteCoat provides access to full suite medical services at your fingertips. Enjoy greater convenience with medication delivered to your doorstep, and retrieve your medical history and documents securely. Since its launch in 2018, WhiteCoat has worked with corporate clients to customise comprehensive, end-to-end corporate healthcare solutions that ensure extensive medical coverage for employees. In line with its commitment to offer a seamless and innovative healthcare experience, WhiteCoat is continuously looking at ways to improve its services and expand its network of doctors, patients and healthcare partners. WhiteCoat is now available in Singapore and Indonesia.

Sentons, Inc. is a venture-backed fabless semiconductor company and the world leader in advanced touch and force sensing solutions. Sentons'​ market defining technology utilizes a combination of ultrasound and direct force sensors, to enable unprecedented ways for users to interact with their personal devices. The result is stunning and intuitive user experiences that extend interactivity to all physical surfaces of a device, beyond the touchscreen. Sentons works with leading OEMs to implement this technology into the next generation of mobile phones, tablets, and other electronic products. Founded in 2011, Sentons is venture funded by New Enterprise Associates and Northern Light Venture Capital. More information is available at www.sentons.com.

HealthBeacon is a medical adherence technology company. We develop smart tools for managing medication.

Join our mission to perfect training data for AI. AI.Reverie creates the data required to produce computer vision AI efficiently, accurately and without bias.

Digital Reputation for Web3 Decentralised Digital ID Infrastructure to Facilitate Onchain Reputation via Proof of Reputation Protocol (PoR)

The Mighty Jaxx Group is a collection of brands and companies that bridges future culture via an integrated platform that curates and produces unique in-person experiences, and develops digital and phygital collectibles for every fandom and audience. With a mission to supercharge future culture globally, we work collaboratively with some of the world’s most iconic brands like Netflix, Disney, Formula 1, Hasbro and Toei Animation, to create unique experiences and deliver happiness for a diverse and global fanbase of collectors in over 90 countries – through our live in-person events, digital and phygital collectibles, innovative technologies, merchandise, and more.

VRcollab boosts BIM’s viability by making it more collaborative, usable and scalable for all stakeholders - allowing for cross-border, cross-discipline collaboration. Offering a common platform that levels barriers, democratises digitalisation, and onboards all AEC stakeholders. Helping users become more confident and take full advantage of digital tools regardless of their role, capacity or skill in their built projects.

Musiio by SoundCloud combines best-in-class AI expertise with specialist music knowledge to solve real music industry problems. We offer industry-leading music search and automated tagging solutions to labels, publishers, streaming services and sync companies. Musiio by SoundCloud currently serves over 75 B2B clients in 11 countries and has analysed over 400 million tracks to date. Formed in 2018 in Singapore, music AI company Musiio was acquired by SoundCloud in 2022 to strengthen the platform’s music discovery, while keeping services available to new and existing industry users. AWARDS - Musiio co-founder Hazel Savage named Entrepreneur of the Year in Music Week’s Women In Music Awards 2022 - Acquisition International Best Specialist AI-Powered Solutions Company 2022 - #4 in Fast Company’s Most Innovative Companies in Music 2022 Try our free demo at: https://musiio.com/home#tag-demo

Datature simplifies the way people build deep-learning capabilities. Using Nexus, our end-to-end #nocode mlops platform, we enable everyone to create AI breakthroughs of their own.

Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA. The Company has assembled a toolkit of disruptive platform technologies – including a high payload capacity HSV platform, a hypoimmunogenic platform, and a genome writing platform – to address the scientific challenges currently limiting clinical progress and preventing genomic medicine from realising its full potential. The Company’s hub-and-spoke business model separates technology development within Replay from therapeutic development in product companies, which leverage the technology platforms. For example, Replay’s synHSV™ technology, a high payload capacity HSV vector capable of delivering up to 30 times the payload of AAV, is utilized by Replay’s four gene therapy product companies, bringing big DNA treatments to diseases affecting the skin, eye, brain, and muscle. The Company has, additionally, established an enzyme writing product company engaging its evolutionary inference machine learning and genome writing technology to optimize functionality. Replay is led by a world-class team of academics, entrepreneurs and industry experts.

Lithium battery recycling is costly, inflexible and inefficient. NEUs mission is to change that. NEU Battery Materials has developed the world’s first electrochemical lithium-ion battery recycling technology, providing a greener, scalable, and commercially viable alternative to conventional processes today. Our patented LFP-first technology enables a near-zero waste recycling process of lithium batteries. We empower automotive OEMs, cell manufacturers, and battery recyclers to lean into LFP batteries knowing there is a circular solution to recover the critical metals. Our modular recycling units only consume water and electricity to extract lithium from end-of-life lithium batteries, removing the need for costly, wasteful acid leaching or smelting processes to extract lithium. Contact us at hello@neumaterials.com Learn more and click the URL below!

Nalagenetics was built with the passion to make preventive, DNA-based precision healthcare accessible to as many people as possible. Specifically, catalyzed by the founders’ personal experiences of problematic medication side effects and knowledge of what genetic testing can offer, Nalagenetics aims to help people achieve better nutrition and prescription medication outcomes by analyzing their unique DNA. Today, Nalagenetics’ solutions are trusted by a growing number of healthcare providers, laboratories, insurers and corporates in Asia and Europe. We have also won government grants and mandates to carry out genomic research projects from the Government of Singapore and others. These achievements reflect the company’s exceptional standards and depth of research as a scientist-led company, along with a commitment to delivering best-in-class genomic solutions. Find out more about us at www.nalagenetics.com

Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.